The MicroIBioM study: the gut microbiome in inclusion body myositis

Key Points

• The research aims to understand the role of the gut microbiome in inclusion body myositis (IBM).
• Analyzed gut microbiome composition in individuals with IBM
• Compared microbiome differences with healthy controls
• Evaluated the relationship between microbiome and disease progression
• General differences in the gut microbiome were found not to contribute to IBM onset.
• Specific microbiome differences may be associated with later stages of the disease but require further research.